Latest in FDA warns companies over unapproved weight loss drug sales
Sort by
1,482 items
-
Merck to develop weight loss pill from Chinese drugmaker in up to $2 billion licensing deal
Merck will pay Hansoh $112 million upfront for rights to the drug, with the potential for an additional $1.9 billion in payments and royalties on sales.CNBC - 10h -
Nuclear bunker sales increase, despite expert warnings they won't provide protection
Global security leaders are warning nuclear threats are growing as weapons spending surged to $91.4 billion last yearABC News - 1d -
Nuclear bunker sales increase, despite expert warnings they aren’t going to provide protection
Global security leaders are warning nuclear threats are growing as weapons spending surged to $91.4 billion last yearABC News - 1d -
Alibaba Expects to Book $1.28 Billion Loss on Sale of Department Store
The sale comes as Alibaba has been restructuring its businesses to focus on the e-commerce sector amid intensifying competition with its Chinese rivals.The Wall Street Journal - 1d -
FDA warns companies over unapproved weight loss drug sales
The Food and Drug Administration (FDA) said Tuesday in a statement it has sent warning letters to companies selling unapproved weight loss drugs. The letter went to Xcel Peptides, Swisschems, ...The Hill - 8h -
Watchdog warns credit card companies over devaluing, canceling reward points, miles
The Consumer Financial Protection Bureau (CFPB) on Wednesday warned that credit card companies devaluing or canceling reward points, cash back or miles rewards programs may be breaking the law. The ...The Hill - 9h -
Tennessee woman accused of selling fake weight loss drugs as counterfeit concerns grow
A Tennessee woman was accused of selling counterfeit versions of popular weight loss drugs including Ozempic. Experts say fakes have exploded in the U.S.NBC News - 1d -
Why the investor craze for Ozempic and rival weight-loss drugs may resume next year
Novo Nordisk’s takeover of Catalent and the Danish firm’s push to launch a new generation of drugs could boost the importance of GLP agonists in 2025, Barclays analysts saidMarketWatch - 2d -
Liverpool FC staff party halted over 'drugs paraphernalia'
Liverpool FC said it does "not tolerate the use of illegal substances" at any of its events or venues.BBC News - 4d -
GOG's Winter Sale Is Now Live, Save On Over 6,500 PC Games
GOG has kicked off its annual Winter Sale, and with discounts on over 6,500 games, there are quite a few tempting deals here, including a long list of classic PC titles that you'll only find at ...GameSpot - 5d -
Four-try Sale cruise to victory over Racing
Sale run out comfortable winners over Racing 92 in their Champions Cup match at Salford Community Stadium.BBC News - 5d -
Porsche holding company warns of writedown in Volkswagen stake of up to €20bn
Management and unions at carmaker will hold a fifth round of talks on Monday over planned factory closures and job cutsFinancial Times - 5d -
McKinsey & Company agrees to pay $650M for helping Purdue Pharma boost opioid sales
McKinsey & Company consulting firm has agreed to pay $650 million to settle a federal investigation into its work for opioids manufacturer Purdue Pharma, according to court papers filed in VirginiaABC News - 5d -
In shift, RFK Jr. now says weight-loss drugs 'have a place'
His remarks come days before he holds confirmation meetings with GOP senators.ABC News - 6d -
Elon Musk contradicts RFK Jr.'s sentiments on weight loss drugs
Elon Musk validated the use of GLP-1 drugs in a post on X on Wednesday. But Robert F. Kennedy Jr. has said he's opposed to Americans using them to fight obesity.ABC News - 6d -
Kerr furious over 'unconscionable' late call in loss
Warriors coach Steve Kerr blasted the officials after a loose ball foul went against his team with 3.5 seconds left in what became a 91-90 loss to the Rockets.ESPN - 6d -
What other conditions could weight-loss drugs treat?
Initial research has focused on obesity, but Ozempic, Wegovy and Mounjaro may potentially be used for addiction, heart disease and Alzheimer’sFinancial Times - 6d -
Ro to offer lower-price vials of weight loss drug Zepbound by teaming up with Eli Lilly
It is made possible through a first-of-a-kind integration with Eli Lilly's direct-to-consumer website, and aims to streamline access to the popular treatment.CNBC - Dec. 11 -
Walgreens in talks over sale to private equity group Sycamore
Potential deal highlights mounting distress facing the retail pharmacy industryFinancial Times - Dec. 10 -
Some health experts warn against microdosing weight loss drugs
The demand for weight loss drugs, like Ozempic and Wegovy, has skyrocketed in the past few years despite the high cost and unpleasant side effects for some people. The New York Times reports some ...CBS News - Dec. 9 -
The weight-loss drug boom has become one of the internet's biggest scams
As demand for obesity drugs like Wegovy, Zepbound, Mounjaro and Ozempic, outpaces supply, online scams are rising, according to cybersecurity experts.CNBC - Dec. 8 -
Horne leads Glasgow to Champions Cup win over Sale
George Horne scores a hat-trick as Glasgow open their Investec Champions Cup campaign with a dominant win over Sale.BBC News - Dec. 7 -
CDC warns of new drug more deadly than fentanyl
A more potent form of fentanyl is contributing to the thousands of overdose deaths that happen every year, health officials warn. An extremely powerful derivative of fentanyl, called carfentanil, ...The Hill - Dec. 6 -
Ulta Beauty’s full-year sales forecast is slightly better, and the company says it’s ‘gaining traction’ in competitive backdrop
Shares of Ulta Beauty Inc. rallied after hours on Thursday after the cosmetics chain offered up a slightly more upbeat full-year sales forecast, saying efforts to counterbalance a slowdown in ...MarketWatch - Dec. 6 -
Weight-loss drug Mounjaro 'changed my life,' says mother-of-two
People struggling with their weight welcome the NHS rollout of Mounjaro but worry about delays.BBC News - Dec. 5 -
China sanctions US defense firms over Taiwan arms sales
China on Thursday sanctioned 13 U.S. defense firms over arms sales to the self-governing island nation of Taiwan. The companies targeted by China are smaller defense tech firms that have worked on ...The Hill - Dec. 5 -
Prescription fills for weight loss drugs Zepbound and Wegovy more than doubled in 2024, GoodRx says
The jump in prescription fills comes despite limited insurance coverage and high out-of-pocket costs for Novo Nordisk's Wegovy and Eli Lilly's Zepbound.CNBC - Dec. 5 -
Millions will have to wait up to 12 years for NHS weight-loss drug
Fears that giving 3.4 million people immediate access to new weight-loss drug could overwhelm NHS.BBC News - Dec. 5 -
‘Climate bomb’ warning over $200bn wave of new gas projects
New liquefied natural gas projects could produce 10 gigatonnes of emissions by the end of the decade, close to the annual emissions of all coal plants. A $200bn wave of new gas projects could lead ...The Guardian - Dec. 5 -
Guardian Journalists Strike Over Planned Sale of The Observer
Workers have begun a 48-hour walkout, the first in 50 years for the outlet, over a proposal to sell The Observer to Tortoise Media, a digital media start-up.The New York Times - Dec. 5 -
Will Trump nix Biden’s coverage plan for weight-loss drugs? It’ll be a close call.
While President-elect Donald Trump looks poised to scrap many policies of the Biden administration, one veteran analyst says it’s possible he could end up supporting the Democratic incumbent’s ...MarketWatch - Dec. 4 -
Zepbound brings more weight loss than Wegovy: Drugmaker
Adults who take Zepbound lose more weight than those who take competitor weight loss drug Wegovy, according to new clinical trial results. Zepound manufacturer Eli Lilly released results from their ...The Hill - Dec. 4 -
Eli Lilly says Zepbound’s weight-loss results beat those of rival Wegovy
Zepbound helped patients lose more weight than a major rival in a head-to-head trial.MarketWatch - Dec. 4 -
A rival weight loss drug to Wegovy helped people shed more pounds, study shows
People who took Zepbound, Eli Lilly’s weight loss drug, shed more pounds than those on Novo Nordisk’s Wegovy in a clinical trial, Lilly said in a release Wednesday.NBC News - Dec. 4 -
Guardian and Observer journalists go on strike over sale of Sunday paper
Their first strike in more than 50 years concerns the proposed sale of the Sunday title to Tortoise.BBC News - Dec. 4 -
Eli Lilly's Zepbound causes greater weight loss than Novo Nordisk's Wegovy in head-to-head trial
Zepbound's greater weight loss is a huge advantage for Eli Lilly, which is competing with Novo Nordisk for a larger share of the weight loss drug market.CNBC - Dec. 4 -
Journalists strike over proposed sale of Observer to Tortoise Media
Forty-eight-hour strike, first at Guardian in more than 50 years, to take place on Wednesday and Thursday. Journalists at the Guardian and the Observer are holding a 48-hour strike in protest at ...The Guardian - Dec. 4 -
Experts create controllable gastric balloon to aid weight loss
Device inflates before eating and contracts afterwards, simulating the effects of having a meal, say scientists. From weight loss jabs to vibrating pills , the obesity crisis has spawned myriad ...The Guardian - Dec. 3 -
Supreme Court hears arguments over FDA’s refusal to approve flavored e-cigarettes
Makers of flavored e-cigarettes brought various cases challenging the FDA’s decision to refuse approval and alleged the agency changed its standards of evaluation on short notice. NBC News’ ...NBC News - Dec. 3 -
Supreme Court divided over FDA block on kid-friendly flavored vapes
With e-cigarette sales booming, the Supreme Court heard arguments over whether the FDA unlawfully blocked approval of more than a million new flavored nicotine products.ABC News - Dec. 2
